PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723113. A total of 2 filers reported holding PEAR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $15 | -86.8% | 765,000 | 0.0% | 0.00% | – |
Q4 2022 | $114 | -99.9% | 765,000 | 0.0% | 0.00% | – |
Q3 2022 | $130,000 | +47.7% | 765,000 | +9.3% | 0.00% | – |
Q2 2022 | $88,000 | -83.4% | 700,000 | +4.5% | 0.00% | – |
Q1 2022 | $531,000 | +45.1% | 670,100 | +10.0% | 0.00% | – |
Q4 2021 | $366,000 | – | 609,114 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LMR Partners LLP | 2,440,169 | $622,243 | 0.01% |
DIFESA CAPITAL MANAGEMENT, LP | 551,435 | $10,477 | 0.01% |
Q Global Advisors, LLC | 250,000 | $5 | 0.00% |
Silver Rock Financial LP | 188,505 | $3,600 | 0.00% |
Arena Investors LP | 126,122 | $2,396 | 0.00% |
ANGELO GORDON & CO., L.P. | 33,332 | $8,500 | 0.00% |
ADVISORY RESEARCH INC | 202,891 | $3,855 | 0.00% |
Hudson Bay Capital Management LP | 109,672 | $2,084 | 0.00% |
Citadel Advisors | 32,668 | $621 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 48,392 | $919 | 0.00% |